Similarly, since mesothelioma cancer cells often have an abundant expression of WT1 (Wilms’ tumor suppressor gene), a trial using dendritic cells (DC) targeting WT1, in conjunction with chemotherapy (platinum/pemetrexed), is ongoing [20]. The gene discussed is WT1; the disease is cancer.